Navigating regulatory complications to determine black lung claims

Estimating future liabilities for even the most basic line of business involves in-depth analysis of data, expert knowledge of modeling, and professional application of assumptions. Black lung liabilities take reserving to an entirely different level.

Black lung compensation is rooted in a complex regulatory and legislative history.

The disease itself—pneumoconiosis—involves sophisticated and often conflicting medical and scientific evidence and opinions. Against a backdrop of social and political turbulence is a labyrinth of complex if not incomprehensible data. These unusual liabilities require actuarial and case reserving models that are truly unique, applying methodologies not used in any other line of business.

In this article, Milliman’s Christine Fleming and Travis Grulkowski discuss legislative and regulatory complications regarding black lung disease, including the highly complex, non-standard actuarial approaches for evaluating and estimating black lung liabilities.